Detalhe da pesquisa
1.
Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions.
J Hepatol
; 80(2): 335-351, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37879461
2.
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
Cardiovasc Diabetol
; 22(1): 59, 2023 03 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36927451
3.
Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities.
Diabetes Obes Metab
; 25(9): 2723-2733, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37311732
4.
Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready-to-use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males.
Diabetes Obes Metab
; 23(12): 2679-2686, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34378307
5.
Inhibition of fatty acid synthase with FT-4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non-alcoholic fatty liver disease: Results from two early-phase randomized trials.
Diabetes Obes Metab
; 23(3): 700-710, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33289350
6.
Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes.
Diabetes Obes Metab
; 22(8): 1292-1301, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32175655
7.
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.
Diabetes Obes Metab
; 21(11): 2429-2439, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31264757
8.
Single-dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK-1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects.
Diabetes Obes Metab
; 20(2): 400-408, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28817223
9.
Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals.
Diabetes Obes Metab
; 20(1): 94-102, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28643356
10.
LAPS Insulin115: A novel ultra-long-acting basal insulin with a unique action profile.
Diabetes Obes Metab
; 19(12): 1722-1731, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28497570
11.
A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin.
Clin Pharmacol Ther
; 115(6): 1383-1390, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38456487
12.
Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH.
Endocrinol Diabetes Metab
; 5(3): e00335, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35388643
13.
A Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Insulin Dimer.
Clin Pharmacol Ther
; 112(1): 125-132, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35390172
14.
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline.
BMJ Open Diabetes Res Care
; 10(1)2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35042751
15.
Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients.
Endocrinol Diabetes Metab
; 4(2): e00217, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33855218
16.
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.
BMJ Open Diabetes Res Care
; 9(1)2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34172436
17.
Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption.
J Clin Endocrinol Metab
; 105(4)2020 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31837264
18.
Glycemic exposure is affected favorably by inhaled human insulin (Exubera) as compared with subcutaneous insulin glargine (Lantus) in patients with type 2 diabetes.
Diabetes Technol Ther
; 11(5): 307-13, 2009 May.
Artigo
Inglês
| MEDLINE | ID: mdl-19537357
19.
Pharmacokinetic and pharmacodynamic differences of new generation, longer-acting basal insulins: potential implications for clinical practice in type 2 diabetes.
Postgrad Med
; 131(2): 117-128, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30691343
20.
Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide.
Diabetes Care
; 42(9): 1733-1741, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31320446